Integer Holdings Co. (NYSE:ITGR) Receives $145.44 Average PT from Brokerages

Integer Holdings Co. (NYSE:ITGR - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $145.44.

Several equities analysts recently issued reports on the company. Citigroup upped their target price on Integer from $130.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, December 11th. Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, October 1st. Piper Sandler reaffirmed an "overweight" rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Wells Fargo & Company reiterated an "overweight" rating and issued a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Finally, Truist Financial lifted their price objective on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th.

Integer Stock Up 1.5 %

NYSE ITGR traded up $2.06 during trading on Tuesday, hitting $143.06. The company's stock had a trading volume of 137,357 shares, compared to its average volume of 165,228. Integer has a fifty-two week low of $94.56 and a fifty-two week high of $144.22. The company has a market cap of $4.80 billion, a PE ratio of 44.15, a P/E/G ratio of 1.80 and a beta of 1.12. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The business's 50 day simple moving average is $136.56 and its 200-day simple moving average is $129.05.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. During the same period last year, the business earned $1.27 EPS. Integer's revenue for the quarter was up 8.7% on a year-over-year basis. On average, equities analysts anticipate that Integer will post 5.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Integer

Several hedge funds have recently modified their holdings of the company. Contravisory Investment Management Inc. increased its stake in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 80 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Integer by 0.8% in the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider's stock worth $1,579,000 after buying an additional 90 shares during the last quarter. Xponance Inc. increased its stake in Integer by 4.9% during the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock worth $245,000 after buying an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV raised its holdings in shares of Integer by 0.9% during the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock valued at $1,504,000 after acquiring an additional 107 shares during the last quarter. Finally, Exchange Traded Concepts LLC lifted its position in shares of Integer by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider's stock valued at $769,000 after acquiring an additional 145 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.